Double Medical Technology Inc (002901) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Double Medical Technology Inc (002901) has a cash flow conversion efficiency ratio of 0.060x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥207.34 Million ≈ $30.34 Million USD) by net assets (CN¥3.44 Billion ≈ $503.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Double Medical Technology Inc to measure how much of total assets are equity-financed.
Double Medical Technology Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Double Medical Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 002901 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Double Medical Technology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Double Medical Technology Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AXT Inc
NASDAQ:AXTI
|
-0.027x |
|
SCG PACKAGING -NVDR- BA1
F:5Y7
|
0.039x |
|
Valiant Holding AG
SW:VATN
|
0.005x |
|
Trustmark Corporation
NASDAQ:TRMK
|
0.013x |
|
Guangxi Liugong Machinery Co Ltd
SHE:000528
|
0.011x |
|
Wuhan Raycus Fiber Laser Technologies Co Ltd Class A
SHE:300747
|
0.033x |
|
Xinyi Solar Holdings Ltd
F:13X
|
0.042x |
|
Russel Metals Inc.
TO:RUS
|
0.066x |
Annual Cash Flow Conversion Efficiency for Double Medical Technology Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Double Medical Technology Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Double Medical Technology Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.69 Billion ≈ $539.27 Million |
CN¥831.34 Million ≈ $121.65 Million |
0.226x | +62.27% |
| 2024-12-31 | CN¥3.18 Billion ≈ $465.57 Million |
CN¥442.30 Million ≈ $64.72 Million |
0.139x | +494.63% |
| 2023-12-31 | CN¥3.16 Billion ≈ $462.50 Million |
CN¥73.89 Million ≈ $10.81 Million |
0.023x | -43.46% |
| 2022-12-31 | CN¥3.11 Billion ≈ $454.56 Million |
CN¥128.44 Million ≈ $18.80 Million |
0.041x | -84.10% |
| 2021-12-31 | CN¥2.59 Billion ≈ $378.76 Million |
CN¥673.26 Million ≈ $98.52 Million |
0.260x | -0.13% |
| 2020-12-31 | CN¥2.13 Billion ≈ $312.26 Million |
CN¥555.77 Million ≈ $81.33 Million |
0.260x | +5.26% |
| 2019-12-31 | CN¥1.75 Billion ≈ $256.59 Million |
CN¥433.88 Million ≈ $63.49 Million |
0.247x | +7.72% |
| 2018-12-31 | CN¥1.46 Billion ≈ $213.33 Million |
CN¥334.88 Million ≈ $49.00 Million |
0.230x | -7.84% |
| 2017-12-31 | CN¥1.24 Billion ≈ $181.24 Million |
CN¥308.70 Million ≈ $45.17 Million |
0.249x | -30.19% |
| 2016-12-31 | CN¥580.13 Million ≈ $84.89 Million |
CN¥207.13 Million ≈ $30.31 Million |
0.357x | +27.78% |
| 2015-12-31 | CN¥441.78 Million ≈ $64.65 Million |
CN¥123.44 Million ≈ $18.06 Million |
0.279x | -49.27% |
| 2014-12-31 | CN¥274.36 Million ≈ $40.15 Million |
CN¥151.12 Million ≈ $22.11 Million |
0.551x | +16.16% |
| 2013-12-31 | CN¥224.61 Million ≈ $32.87 Million |
CN¥106.51 Million ≈ $15.59 Million |
0.474x | -- |
About Double Medical Technology Inc
Double Medical Technology Inc. engages in the research, development, production, and sale of high-value medical consumables in China. The company offers orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical implants, and dental implants. It also exports its products. The company was formerly known as Xiamen Da Bo Ying J… Read more